Patients are taking part in a trial that scientists hope could ultimately lead to a cure for rheumatoid arthritis.

The AuToDeCRA-2 study seeks to prove it is possible to train white blood cell commanders - dubbed the “generals” of the immune system - to order other “soldier” cells to stop attacking healthy tissues.